ISSN (Print): 2374-1996

ISSN (Online): 2374-2003

Website: http://www.sciepub.com/journal/jcrt

Editor-in-chief: Jean Rommelaere

You are here

Currrent Issue: Volume 4, Number 6, 2016

Article

The Impact of Polycystic Ovarian Syndrome, a Potential Risk Factor to Endometrial Cancer, on the Quality of Sleep

1Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta, Egypt

2Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia

3PharmD candidate, Taif, Saudi Arabia

4Dermatology specialist, Ministry of Health, Egypt


Journal of Cancer Research and Treatment. 2016, 4(6), 96-98
doi: 10.12691/jcrt-4-6-1
Copyright © 2016 Science and Education Publishing

Cite this paper:
Ahmed M. Kabel, Ali Y. Alghubayshi, Fatma M. Moharm. The Impact of Polycystic Ovarian Syndrome, a Potential Risk Factor to Endometrial Cancer, on the Quality of Sleep. Journal of Cancer Research and Treatment. 2016; 4(6):96-98. doi: 10.12691/jcrt-4-6-1.

Correspondence to: Ahmed  M. Kabel, Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta, Egypt. Email: drakabel@gmail.com

Abstract

Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in women during their reproductive age. Recent studies showed that PCOS may be a risk factor to the development of endometrial cancer. This risk factor may be associated with sleep disorders including sleep-disordered breathing and excessive daytime sleepiness. The mechanisms leading to this high prevalence of sleep disorders in PCOS have not yet been identified. However, possible causes include alterations in body fat composition due to excess androgen levels and/or the effects of the metabolic syndrome. These effects on sleep disorders may have an impact on daily physical activities.

Keywords

References

[1]  Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Archives of Internal Medicine 2005; 165: 447-52.
 
[2]  Chen J, Shen S, Tan Y, Xia D, Xia Y, Cao Y, et al. The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome. J Ovarian Res 2015; 8: 11.
 
[3]  Chowdhuri S, Bascom A, Mohan D, Diamond MP, Badr MS. Testosterone Conversion Blockade Increases Breathing Stability in Healthy Men during NREM Sleep. Sleep 2013; 36(12): 1793-8.
 
[4]  de Oliveira DL, Albuquerque RG, Hirotsu C. Vitamin D and obstructive sleep apnea: an unexplored relationship in PCOS patients. Endocrine 2016; 53(2): 617-8.
 
[5]  de Sousa G, Schluter B, Menke T, Trowitzsch E, Andler W, Reinehr T. A comparison of polysomnographic variables between adolescents with polycystic ovarian syndrome with and without the metabolic syndrome. Metab Syndr Relat Disord 2011; 9(3): 191-6.
 
Show More References
[6]  Driver HS, McLean H, Kumar DV, Farr N, Day AG, Fitzpatrick MF. The influence of the menstrual cycle on upper airway resistance and breathing during sleep. Sleep 2005; 28: 449-56.
 
[7]  El-Sharkawy AA, Abdelmotaleb GS, Aly MK, Kabel AM. Effect of metformin on sleep disorders in adolescent girls with polycystic ovarian syndrome. J Ped Adol Gynecol 2014; 27(6): 347-52.
 
[8]  Firouzi S, Poh BK, Ismail MN, Sadeghilar A. Sleep habits, food intake, and physical activity levels in normal and overweight and obese Malaysian children. Obesity Research & Clinical Practice 2014; 8(1): e70-e78.
 
[9]  Gateva A, Kamenov Z, Mondeshki Ts, Bilyukov R, Georgiev O. Polycystic ovarian syndrome and obstructive sleep apnea. Akush Ginekol (Sofiia) 2013; 52(3): 63-8.
 
[10]  Hursel R, Rutters F, Gonnissen H K, Martens EA, Westerterp-Plantenga MS. Effects of sleep fragmentation in healthy men on energy expenditure, substrate oxidation, physical activity, and exhaustion measured over 48 h in a respiratory chamber. Am J Clin Nutr 2011; 94(3): 804-8.
 
[11]  Joseph-Horne R, Mason H, Batty S, White D, Hillier S, Urquhart M, et al. Luteal phase progesterone excretion in ovulatory women with polycystic ovaries. Hum Reprod 2002; 17: 1459-63.
 
[12]  Kabel AM. Polycystic Ovarian Syndrome: Insights into Pathogenesis, Diagnosis, Prognosis, Pharmacological and Non-Pharmacological Treatment. J Pharma Reports 2016; 1: 103.
 
[13]  Khoury J, Doghramji K. Primary Sleep Disorders. Psychiatr Clin North Am 2015; 38(4): 683-704.
 
[14]  Kische H, Ewert R, Fietze I, Gross S, Wallaschofski H, Völzke H, et al. Sex Hormones and Sleep in Men and Women From the General Population: A Cross-Sectional Observational Study. J Clin Endocrinol Metab 2016; 101(11): 3968-77.
 
[15]  McGlinchey EL, Gershon A, Eidelman P, Kaplan KA, Harvey AG. Physical activity and sleep: Day-to-day associations among individuals with and without bipolar disorder. Mental Health and Physical Activity 2014; 7(3): 183-90.
 
[16]  Nandalike K, Agarwal C, Strauss T, Coupey SM, Isasi CR, Sin S, et al. Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome. Sleep Medicine 2012; 13: 1307-12.
 
[17]  Nandalike K, Strauss T, Agarwal C, Coupey SM, Sin S, Rajpathak S, et al. Screening for Sleep-Disordered Breathing and Excessive Daytime Sleepiness in Adolescent Girls with Polycystic Ovarian Syndrome. J Ped 2011; 159 (4): 591-6.
 
[18]  Ndefo UA, Eaton A, Green MR. Polycystic Ovary Syndrome: A Review of Treatment Options With a Focus on Pharmacological Approaches. Pharmacy and Therapeutics 2013; 38(6):336-55.
 
[19]  Nitsche K, Ehrmann DA. Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2010; 24 (5): 717-30.
 
[20]  Polo-Kantola P, Rauhala E, Helenius H, Erkkola R, Irjala K, Polo O. Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol 2003; 102: 68-75.
 
[21]  Steiger A. Roles of peptides and steroids in sleep disorders. Expert Review of Endocrinology & Metabolism 2006; 1(5): 609-22.
 
[22]  Tal JZ, Suh SA, Dowdle CL, Nowakowski S. Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic Approaches. Current psychiatry reviews 2015; 11(1):63-83.
 
[23]  Tasali E, Chapotot F, Leproult R, Whitmore H, Ehrmann DA. Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2011; 96: 365-74.
 
[24]  Terán-Pérez G1, Arana-Lechuga Y, Esqueda-León E, Santana-Miranda R, Rojas-Zamorano JÁ, Velázquez Moctezuma J. Steroid hormones and sleep regulation. Mini Rev Med Chem 2012; 12(11): 1040-8.
 
[25]  Venâncio DP, Tufik S, Garbuio SA, da Nóbrega AC, de Mello MT. Effects of anabolic androgenic steroids on sleep patterns of individuals practicing resistance exercise. Eur J Appl Physiol 2008; 102(5): 555-60.
 
[26]  Zheng MX, Li Y, Hu R, Wang FM, Zhang XM, Guan B. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance. J Assist Reprod Genet (2016) 33: 199.
 
Show Less References